PEPG · PepGen Inc.
Market Cap
$215.40M
Shares
69.26M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $3,316,783 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,758,882 |
| Joseph D. Vittiglio | J.D., Chief Business and Legal Officer | $1,319,816 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $4,426,218 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $2,349,969 |
| Paul Streck | M.D., M.B.A. Executive Vice President, Head of Research & Development | $2,072,267 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $3,425,703 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,973,551 |
| Michelle Mellion | Senior Vice President, Clinical Development | $1,411,171 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $4,511,477 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,983,872 |
| Niels Svenstrup | Senior Vice President, Chemistry, Manufacturing and Controls | $1,322,057 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $4,088,874 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,775,211 |
Key facts
CIK
1835597
CUSIP
713317105
13F (30d)
59 filings
59 filers
Visit website
Investor relations